The affirmation is a result of several factors, including Main Line Health’s healthy market position, favorable service area, strong balance sheet metrics, light debt burden and exceptional debt coverage. The credit agency noted the health system’s upcoming period of increased capital spending, competitive region and considerable unfunded pension liabilities.
The outlook is stable, reflecting Moody’s expectation that the health system will maintain healthy margins to produce a strong balance sheet and leverage ratios during a period of heightened capital spending.
More articles on healthcare finance:
For-profit hospital operators by the numbers: A look at HCA, Tenet, CHS, LifePoint and UHS
HCA’s profit jumps 25% to $820M in Q2
CHS sees net loss narrow to $110M, pursues $2B hospital divestiture plan
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
